U.S. Hemophilia Treatment Market SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2024 - 2031)

U.S. Hemophilia Treatment Market is Segmented By Product Type (Recombinant Coagulation Factor, Plasma Derived Coagulation Factor, Antifibrinolytic Agents, and Others), By Disease Type (Hemophilia A, Hemophilia B, and Hemophilia C), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies). The report offers the value (in USD billion) for the above-mentioned segments.

U.S. Hemophilia Treatment Market is Segmented By Product Type (Recombinant Coagulation Factor, Plasma Derived Coagulation Factor, Antifibrinolytic Age....

U.S. Hemophilia Treatment Market Leaders

Takeda Pharmaceutical Company Limited
Sanofi Octapharma AG
Swedish Orphan Biovitrum AB
Baxter International Inc.
Biogen Inc.

*Disclaimer: Major players are listed in no particular order.

U.S. Hemophilia Treatment Market - Company List

Takeda Pharmaceutical Company Limited
Sanofi Octapharma AG
Swedish Orphan Biovitrum AB
Baxter International Inc.
Biogen Inc.
Bayer AG
CSL Behring
Ferring B.V.
Pfizer, Inc.
Kedrion
Novo Nordisk A/S
Grifols S.A.
Sangamo Therapeutics, Inc.
Spark Therapeutics, Inc.

U.S. Hemophilia Treatment Market Report Snapshots

Buy Now